Skip to content

Nationwide internet-delivered computer-assisted cognitive-behavioral therapy (iCBT) for psychiatric disorders

Guided internet-delivered computer-assisted cognitive-behavioral therapy for psychiatric disorders - a nationwide naturalistic prospective effectiveness study.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN55123131
Enrollment
5000
Registered
2019-08-26
Start date
2015-09-15
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive disorders, General Anxiety Disorder, Panic Disorder, Social Anxiety Disorder, Obsessive-Compulsive Disorder Mental and Behavioural Disorders Depressive disorders, General Anxiety Disorder, Panic Disorder, Social Anxiety Disorder, Obsessive-Compulsive Disorder

Interventions

All physicians registered in Finland are authorized to refer their patients with a number of ICD-10 verified psychiatric disorders (mostly depressive and anxiety disorders) to municipality-purchased,
Bulimia Nervosa program is available soon.

Sponsors

Hospital District of Helsinki and Uusimaa
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of a psychiatric disorder being explored 2. Aged 18 years or more 3. Reasonable command of Finnish language 4. Access to the internet 5. Provided informed consent 6. Referral to the HUS-iCBT by the patient’s treating physician

Exclusion criteria

Exclusion criteria: 1. Reported or observed suicidal intentions 2. Current alcohol misuse as judged by referring physician 3. Known diagnosis of schizophrenia or other psychotic disorder, bipolar disorder or serious personality disorder 4. Neurologic or neuropsychiatric disorder that adversely affects the patient’s cognitive performance

Design outcomes

Primary

MeasureTime frame
Primary outcomes are a disorder-specific symptom measure scale. For each specific disorder, we measure one or two pertinent symptom scales as primary measures: Beck’s Depression Inventory (BDI) for Depressive Disorders, Panic Disorder Severity Scale (PDSS-SR) for Panic disorder, Generalized Anxiety Disorder 7-item Scale (GAD-7) and Penn State Worry Questionnaire (PSWQ) for Generalized Anxiety Disorder, Obsessive-Compulsive Inventory, short version (OCI-R) for Obsessive-Compulsive Disorder, Social Phobia Inventory, Finnish version (SPIN-FIN) for Social Anxiety Disorder and Sleep Disorders, and Eating Disorder Examination Questionnaire (EDE-Q), the Eating Disorder Examination-Self-Report Questionnaire Version (EDE-Q) for Bulimia Nervosa. The scales are applied at baseline, mid-treatment and endpoint with the exception of GAD-7 which is applied as each session. All measures are filled in by patients online.

Secondary

MeasureTime frame
1. Overall Anxiety Severity and Impairment Scale (OASIS) assessed at baseline and mid-treatment 2. Health-Related Quality of Life scale 15D at baseline, end-point and three months follow-up

Countries

Finland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 18, 2026